US › Healthcare

Anbio Biotechnology Class A Ordinary Shares (NNNN)

US · Healthcare · Medical Instruments & Supplies

$10.15-4.69%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$4.7M

Revenue YoY

-25.1%

Net profit

$3.0M

Profit YoY

-21.8%

EPS

$0.09

EPS estimate

$0.00

Net margin

64.1%

Key statistics

Market cap

$434.5M

P/E

66.0

Forward P/E

0.0

P/B

14.73

Book value

$0.69

EPS (TTM)

$0.15

52-week high

$54.95

52-week low

$8.30

50-day MA

$17.04

200-day MA

$24.30

Shareholding

Insiders

4.78%

Institutions

4.90%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.06%
BNP Paribas Arbitrage, SA	0.02%
Morgan Stanley - Brokerage Accounts	0.02%
UBS Group AG	0.01%
EverSource Wealth Advisors, LLC	0.00%
Wells Fargo & Co	0.00%
Bare Financial Services Inc	0.00%
Ronald Blue Trust, Inc.	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Anbio Biotechnology Class A Ordinary Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.